Moving fast or moving slow: an overview of Movement Disorders

Similar documents
Dr Barry Snow. Neurologist Auckland District Health Board

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

Issues for Patient Discussion

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

Professor Tim Anderson

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Optimizing Clinical Communication in Parkinson s Disease:

Professor Tim Anderson

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Movement Disorders. Eric Kraus, MD! Neurology!

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders

Update on Parkinson s disease and other Movement Disorders October 2018

Understanding Parkinson s Disease Important information for you and your loved ones

Best Medical Treatments for Parkinson s disease

Part I Parkinson Disease Diagnosis and Treatment

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Parkinson s Disease. Sirilak yimcharoen

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Parkinson's Disease KP Update

10th Medicine Review Course st July Prakash Kumar

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

THE ART OF MEDICATION MANAGEMENT IN PARKINSON S DISEASE

Treatment of Parkinson s Disease: Present and Future

Differential Diagnosis of Hypokinetic Movement Disorders

PARKINSON S DISEASE OVERVIEW, WITH AN EMPHASIS ON PHYSICAL WELLBEING. Gillian Quinn MISCP, Senior Physiotherapist in Neurology, SVUH

PARKINSON S DISEASE 馬 萬 里. Chinese character for longevity (shou) Giovanni Maciocia

Managing Movement Disorders in the older patient

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Parkinson s Disease. Gillian Sare

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

Source: *Dystonia facts medically edited by: Charles Patrick Davis, MD, PhD

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Extrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010

Headway Victoria Epilepsy and Parkinson s Centre

Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

How to Effectively Manage the Motor Symptoms of HD

Prior Authorization with Quantity Limit Program Summary

Objectives. Emerging Treatments in Parkinson s s Disease. Pathology. As Parkinson s progresses it eventually affects large portions of the brain.

Faculty. Joseph Friedman, MD

EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS

Evaluation and Management of Parkinson s Disease in the Older Patient

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

The motor regulator. 1) Basal ganglia/nucleus

The PD You Don t See: Cognitive and Non-motor Symptoms

Tremor 101. Objectives 9/30/2015. Importance of tremors

Enhanced Primary Care Pathway: Parkinson s Disease

Dysarthria and Dysphagia: a Neurology Perspective William Meador, MD Assistant Professor of Neurology, UAB

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

The PD You Don t See: Cognitive and Non-motor Symptoms

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease

III./3.1. Movement disorders with akinetic rigid symptoms

Non-Motor Symptoms of Parkinson s Disease

Hyperkinetic movement disorders are. Hyperkinetic Movement Disorders. Cases in Movement Disorders. James case. About Tom

PARKINSON S MEDICATION

Basal ganglia Sujata Sofat, class of 2009

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Motor Fluctuations in Parkinson s Disease

Parkinson s Disease Current Treatment Options

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

RAMBAM. Revolutionary New Treatment for Parkinson s Disease Tremors. Health Care Campus. Information Guide & Treatment Options

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

Exercise in Parkinson s the new drug

Movement Disorders: A Brief Overview

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

of common terms Amplitude Resting Position Essential Tremor (ET) Glossary

8/28/2017. Behind the Scenes of Parkinson s Disease

Parts of the motor circuits

2-The age at onset of PD is variable, usually between 50 and 80 years, with a mean onset of 55 years (1).

Understanding Dystonia

Origins. Update on Parkinson s Disease

Alison Charleston 1 st September 2016

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

PD ExpertBriefings: Parkinson s Medications: Today and Tomorrow Led By: Cynthia L. Comella, M.D., F.A.A.N.

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

DYSTONIA. Mysi05/Shutterstock

Dystonia: Title. A real pain in the neck. in All the Wrong Places

Parkinson s Disease An Open Doors Perspective

Postural instability Hypokinesia Rigidity Tremor Forward flexed posture. pain million people 50+ years old 10 most populated countries

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

An Approach to Patients with Movement Disorders

Identification number: TÁMOP /1/A

Parkinson s Disease in 60 minutes. Dr. Claire Hinnell Movement Disorder Neurologist Director Movement Disorder Clinic JPOCSC

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS)

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

THE CLINICAL USE OF BOTULINUM TOXIN IN THE TREATMENT OF MOVEMENT DISORDERS, SPASTICITY, AND SOFT TISSUE PAIN

Treatment of Parkinson s Disease and of Spasticity. Satpal Singh Pharmacology and Toxicology 3223 JSMBS

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff

Communicating About OFF Episodes With Your Doctor

Data Collection Worksheets

Dystonias. How are the dystonias classified? One way of classifying the dystonias is according to the parts of the body they affect:

DISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

Transcription:

Moving fast or moving slow: an overview of Movement Disorders Mini Medical School October 25, 2018 Heather Rigby, MD, FRCPC 2014 MFMER slide-1

2014 MFMER slide-2

Basal Ganglia Dysfunction - Movement Disorders Hypokinetic Parkinson s Disease Dystonia Hyperkinetic Huntington s disease Tremor 2014 MFMER slide-3

Prevalence of Movement Disorders Disorder Estimated Prevalence Essential Tremor 300-400/100,000 Parkinson s Disease 200-350/100,000 Dystonia 30-50/100,000 Tic Disorders 40-50/100,000 Huntington Disease 4-8/100.000 2014 MFMER slide-4

James Parkinson (1755-1824) Involuntary with a propensity the tremulousness in and senses to pass to and bend with from intellects the lessened a parts walking trunk being not forwards muscular to a action uninjured running and power pace even when supported 2014 MFMER slide-5

2014 MFMER slide-6

Who gets Parkinson s disease? 1-2% of population > 50 years old Median age is 60 years Males and females All races Cause is unknown Directly inherited in a minority of cases (5-10%) Risk factor genes Weak links with rural living, exposure to well water, pesticides, wood pulp mills, etc. 2014 MFMER slide-7

Motor Symptoms Tremor Stiff Weak Slowed down Clumsy molasses Handwriting changes 2014 MFMER slide-8

Motor Symptoms Poor balance Shuffling Dragging leg Decreased arm swing Speech quieter Less facial animation 2014 MFMER slide-9

2014 MFMER slide-10

2014 MFMER slide-11

Cardinal Motor Signs 1. Rest Tremor 2. Rigidity (stiffness) 3. Bradykinesia (slowness of movement) 2014 MFMER slide-12

Disease(Onset( Diagnosis( Increase( Nonmotor( Symptoms( Motor(( Symptoms( Decrease( Dopamine( Neurons( Premotor(Phase( Motor(Phase( Time((y)( 2014 MFMER slide-20

Pre-motor symptoms 2014 MFMER slide-21

2014 MFMER slide-22

As the disease progresses Depression/Anxiety Urinary dysfunction Daytime sleepiness Swallowing difficulty Cognitive impairment Hallucinations Falls 2014 MFMER slide-23

Exercise Benefits supported by research Components Stretching Aerobic activity Resistance training / strengthening Examples Walking, biking, Tai Chi, Yoga, Pilates, dance, swimming 2014 MFMER slide-24

Medications Replace Dopamine Levodopa Dopamine Agonists Block Degredation of Dopamine MAOB Inhibitors (Rasagline and Selegiline) COMT Inhibitor (Entacapone) 2014 MFMER slide-25

2014 MFMER slide-27

2014 MFMER slide-28

2014 MFMER slide-31

2014 MFMER slide-32

Major ICDs 1. Gambling 2. Buying 3. Hypersexuality 4. Eating 2014 MFMER slide-33

Deep Brain Stimulation 2014 MFMER slide-34

DUODOPA Intestinal Infusion System 2014 MFMER slide-35

Carrying Accessories 2014 MFMER slide-36

Caudate Atrophy 2014 MFMER slide-38

Clinical Features Movement Disorder Psychiatric Disturbance Cognitive Decline 2014 MFMER slide-39

2014 MFMER slide-40

2014 MFMER slide-41

Essential Tremor Bilateral postural and kinetic tremor of the hands; can have head and voice tremor Generally no other neurologic signs Alcohol responsive Positive family history is common (30-60%) 2014 MFMER slide-43

2014 MFMER slide-44

Cervical Dystonia 2014 MFMER slide-45

2014 MFMER slide-46

What are other types of primary focal dystonia? Blepharospasm Jaw-opening / jaw-closing dystonia Musician dystonia Spasmodic dysphonia 2014 MFMER slide-49

2014 MFMER slide-50

Botulinum Toxin (Botox, Xeomin) 2014 MFMER slide-51

Botulinum Toxin Neurotoxin produced by the bacterium Clostridium botulinum 2014 MFMER slide-52

Natural History of Clinical Response Kick-in 3-10 days Peak effect 2-4 weeks Duration of benefit 10-20 weeks 2014 MFMER slide-53

Basal Ganglia Dysfunction - Movement Disorders Hypokinetic Parkinson s Disease Dystonia Hyperkinetic Huntington s disease Tremor 2014 MFMER slide-54